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Valorisation 
Aortic aneurysm is a life-threatening, pathological condition characterized by 
permanent dilation of the aorta. Aortic aneurysm is associated with male gender, advanced age, 
hypertension, genetic diseases and lifestyle factors such as smoking. Because of lack of 
understanding of the pathology underlying aneurysm formation, no pharmacotherapy is yet 
recommended to reduce risk of aortic aneurysm progression and rupture. Current management 
of aneurysms relies exclusively on surgical repair in order to prevent rupture. Decision for the 
type of repair requires careful assessment of rupture risk, specific feature or anatomy, life-
expectancy, and patient’s preference. Although medical advancement enables less invasive 
surgical treatments such as Endovascular aneurysm repair (EVAR) over the previous decade. 
EVAR comes with higher reintervention rate and cost.  
Better knowledge of basic mechanisms underlying aortic aneurysm will open up novel 
avenues for intervention and disease management. Key areas which offer great opportunities 
to advance knowledge regarding aneurysm formation have been proposed by medical experts 
in the field and include the following topics: 1. definition of etiologic factors responsible for 
development of aortic aneurysm, with an emphasis on elucidating biological mechanisms by 
which specific risk factors might act to promote aortic disease such as atherosclerosis and 
hypertension; 2. elucidation of genetic loci for an inherited predisposition; 3. better definition 
of the cellular and molecular pathophysiology of aneurysms, with emphasis on the mechanisms 
underlying progressive destruction of aortic wall. This includes the role of specific proteinases, 
nature of immune response, and better understanding of the role of VSMC in disease initiation 
and progression.5 
The research described in this thesis aims to unravel mechanisms underlying aortic 
aneurysm formation. We characterized VSMCs from aortic aneurysm tissue with specific focus 
on the involvement of vascular calcification in the pathogenesis of abdominal aortic aneurysm. 
Moreover, we studied the effect of smoking, the strongest life-style risk factor for development 
of aneurysm, on VSMCs and explored the role of vitamin K as potential anti-calcific and 
antioxidant therapy in vascular pathologies.  
Current implications of vitamin K and vitamin K dependent proteins in cardiovascular 
diseases are described in Chapter 2. The importance of VSMCs in vascular pathologies, with a 
focus on aortic aneurysm, is emphasized in Chapter 3. In this chapter, we extended on current 
knowledge by providing an insight in the involvement of vitamin K-dependent processes in 
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aortic aneurysm and shed light on potential treatment mechanisms with the nutraceutical 
vitamin K to prevent vascular calcification induced aortic aneurysm formation and progression. 
In Chapter 4, we characterized VSMCs from aneurysm patients and compared 
apparently healthy VSMCs and VSMCs from the abdominal aneurysm of the same patient. 
Understanding the basic pathologies of aortic aneurysm promote emergence of new approaches 
that would result in a better disease management. The findings in this chapter extend the current 
knowledge of aneurysmal VSMCs characteristic and morphology which has mainly been 
described based on studies in animal models. Importantly, we report that aneurysmal VSMCs 
are less contractile, increase extracellular vesicle release, and calcified more than control 
VSMCs. Our findings emphasize the importance of VSMCs in aortic aneurysm and its 
significant role in mediating vascular microcalcification which is observed during aortic 
aneurysm progression. Indeed, use of 18F-NaF to detect microcalcification recently became a 
promising additive tool to predict aneurysm progression and clinical events. It is particularly 
useful for patients in which the decision to intervene is challenging. We put forward (micro) 
calcification as an important risk factor amendable for intervention in AAA. Thus, targeting of 
VSMCs and extracellular vesicles may prevent vascular microcalcification and thus reduce 
aggravation of aortic diseases.   
In a pilot study, we showed that aneurysmal tissue is positive for (inactive) ucMGP, a 
marker used for indication of vascular vitamin K deficiency. Vascular vitamin K deficiency is 
associated with increased vascular calcification. Future studies in aneurysm patients measuring 
plasma inactive ucMGP as biomarker might provide insight on aortic aneurysm risk, hence 
provide a novel treatment area using vitamin K to improve vitamin K status. 
 Nicotine is known for its devastating effects on the vasculature. It increases risk of 
atherosclerotic calcification and abdominal aortic aneurysm. In Chapter 5 we investigated the 
molecular mechanisms how nicotine potentially affects the vasculature. We revealed that 
smoking is associated with higher degree of microcalcification in atherosclerotic plaques and 
unravel a potential mechanism by which nicotine affects VSMC via Nox5-mediated pro-
calcific processes. We demonstrated the involvement of α3 and α7 nicotine acetylcholine 
receptor in nicotine-induced VSMC pathologies which thus serve as potential targets for 
pharmacological intervention. Moreover, we show that downstream of nicotine binding to the 
nAChr induces oxidative stress and causes extracellular vesicle mediated calcification. Our 
data contribute to the understanding of how nicotine not only affects atherosclerotic plaque 
calcification, but possibly also other VSMC-mediated vascular diseases, such as hypertension 
and aortic aneurysm. Because nicotine is the primary agent in both cigarettes and e-cigarettes, 
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our findings also add to the current knowledge that vaping may not be a better and healthier 
choice for vascular health.  
In chapter 5, we provide evidence that vitamin K2, besides being a cofactor for the 
carboxylation of matrix Gla-protein to inhibit vascular calcification, is an effective antioxidant 
ameliorating nicotine-induced oxidative stress and extracellular vesicle release, subsequently 
inhibiting calcification of VSMCs. Vitamin K2 is naturally present in fermented food and is 
also available as supplement. The use of vitamin K2 is an easy, safe and cost-effective way to 
maintain vascular health and prevent vascular disease. In chapter 6, we further provide 
evidence on cardiovascular promoting effects of vitamin K2 in vivo. Using an animal model of 
atherosclerosis, we show that discontinuation of VKA and switch to supplementation with 
vitamin K2 prevents vascular calcification and reduces atherosclerotic plaque progression. Our 
findings emphasized an adequate status of vitamin K2 for vascular health and put forward 
clinical implications of vitamin K2 supplementation to treat cardiovascular diseases. 
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